Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Ann Thorac Surg. 2008 Nov;86(5):1576–1583. doi: 10.1016/j.athoracsur.2008.06.076

Table 1.

Plasma concentrations of endothelin and cytokines at baseline, cross clamp release (CCR), and 0 hour.

Time
Two-way ANOVA
Baseline CCR 0 Hour: Infusion F-value P-value


Endothelin (fmol/mL)
Treatment Vehicle 2.8 ± 0.4 3.3 ± 0.4 2.9 ± 0.4 Time 1.02 0.36
0.1 mg/kg 3.0 ± 0.5 3.9 ± 0.6 3.8 ± 1.1 Treatment 4.15 0.04
0.5 mg/kg 2.5 ± 0.4 3.7 ± 0.5 4.4 ± 1.0
1 mg/kg 4.1 ± 0.6 5.1 ± 0.9 4.1 ± 1.1
2 mg/kg 3.3 ± 0.7 4.9 ± 1.1 5.8 ± 1.4
Interleukin 6 (pg/mL)
Treatment Vehicle 8.0 ± 2.2 46.4 ± 26.1 88.1 ± 47.2 Time 9.80 <0.01
0.1 mg/kg 9.1 ± 2.3 39.2 ± 9.0 80.4 ± 20.6 Treatment 0.05 0.83
0.5 mg/kg 8.5 ± 2.1 49.6 ± 11.0 79.0 ± 16.9
1 mg/kg 10.3 ± 1.8 40.4 ± 15.6 95.2 ± 44.0
2 mg/kg 8.4 ± 2.4 39.3 ± 10.5 71.2 ± 17.9
Interleukin 10 (pg/mL)
Treatment Vehicle 3.0 ± 0.9 17.1 ± 8.2 18.0 ± 8.1 Time 2.04 0.13
0.1 mg/kg 4.0 ± 1.8 30.7 ± 20.5 36.5 ± 24.5 Treatment 0.03 0.86
0.5 mg/kg 3.2 ± 0.7 13.2 ± 7.2 14.2 ± 6.4
1 mg/kg 5.2 ± 1.1 10.7 ± 4.3 26.4 ± 12.1
2 mg/kg 3.6 ± 0.8 7.0 ± 1.8 6.4 ± 1.3
Tumor Necrosis Factor (TNF:pg/mL)
Treatment Vehicle 4.8 ± 1.8 0.5 ± 0.1 0.7 ± 0.1 Time 0.03 0.97
0.1 mg/kg 2.9 ± 0.8 1.9 ± 0.6 2.3 ± 0.7 Treatment 1.79 0.18
0.5 mg/kg 3.8 ± 1.0 1.2 ± 0.3 0.9 ± 0.2
1 mg/kg 7.3 ± 1.9 15.5 ± 8.3 27.2 ± 15.1
2 mg/kg 4.6 ± 1.9 5.6 ± 3.2 4.02 ± 2.1
TNF Receptor I (ng/mL)
Treatment Vehicle 2.73 ± 1.35 2.34 ± 0.30 5.00 ± 1.01 Time 13.62 <0.01
0.1 mg/kg 2.16 ± 0.71 2.67 ± 0.16 4.02 ± 0.23 Treatment 0.10 0.75
0.5 mg/kg 2.12 ± 0.60 3.18 ± 0.54 4.86 ± 0.55
1 mg/kg 2.65 ± 0.84 3.54 ± 0.69 7.14 ± 1.26
2 mg/kg 1.80 ± 0.28 2.59 ± 0.11 5.24 ± 0.71
TNF Receptor II (ng/mL)
Treatment Vehicle 0.53 ± 0.08 0.59 ± 0.05 1.03 ± 0.18 Time 11.22 <0.01
0.1 mg/kg 0.46 ± 0.09 0.62 ± 0.07 0.85 ± 0.05 Treatment 1.01 0.32
0.5 mg/kg 0.53 ± 0.05 1.02 ± 0.29 1.32 ± 0.22
1 mg/kg 0.60 ± 0.13 0.73 ± 0.13 1.35 ± 0.27
2 mg/kg 0.50 ± 0.06 0.72 ± 0.07 1.11 ± 0.15

0 Hour: Separation from cardiopulmonary bypass and time of infusion. Treatment indicates patient randomized to vehicle or ET-AR Antagonist. ANOVA: analysis of variance. Vehicle: n = 9, 0.1 mg/kg: n=9, 0.5 mg/kg: n=9, 1 mg/kg: n=9, 2 mg/kg: n=8.